Weekly NIH Funding Opportunities and Notices

NIH Guide for Grants and Contracts

April 26, 2019
Table of Contents (TOC)
Web Version

Notices

Request for Information (RFI) Regarding Tissue Source Options for Generating Human Immune System (HIS) Mice
(NOT-OD-19-093)
Division of Program Coordination, Planning and Strategic Initiatives,
Office of Research Infrastructure Programs
National Institute of Allergy and Infectious Diseases
Notice of the Publication of Revised NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
(NOT-OD-19-106)
National Institutes of Health
Request for Information (RFI): Inviting comments and suggestions for the development of the NIA Longitudinal Rat Resource to study neural and behavioral trajectories of successful cognitive aging (NOT-AG-19-017)
National Institute on Aging
Notice of Correction to NOT-AG-19-007, "Notice of Special Interest: High-Priority Research Topics for PAR-19-071"
(NOT-AG-19-019)
National Institute on Aging
Notice of Intent to Publish: Funding Opportunity Announcement for Human Immune-Representing Oncology Models for Immuno-Oncology Research (R33 Clinical Trial Optional)
(NOT-CA-19-047)
National Cancer Institute
Notice of NIDCR's Participation in PAR-19-193 "Microbial-based Cancer Therapy-Bugs as Drugs (R01- Clinical Trial Not Allowed)"
(NOT-DE-19-006)
National Institute of Dental and Craniofacial Research
Notice of NIDCR's Participation in PAR-19-194 "Microbial-based Cancer Therapy-Bugs as Drugs (R21- Clinical Trial Not Allowed)"
(NOT-DE-19-007)
National Institute of Dental and Craniofacial Research
Notice of Information: NIH In-Kind Participation in Belmont Forum Collaborative Research Action (CRA) on Climate, Environment and Health (CEH)
(NOT-ES-19-014)
National Institute of Environmental Health Sciences
John E. Fogarty International Center
Notice of Change in Candidate Eligibility for PAR-18-726 "NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)"
(NOT-EY-19-026)
National Eye Institute
Notice of Change in the NEI K23 Eligibility Requirements
(NOT-EY-19-027)
National Eye Institute
Notice of Change in the NEI K08 Eligibility Requirements
(NOT-EY-19-028)
National Eye Institute
Request for Information: Research Plan on Rehabilitation
(NOT-HD-19-006)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Notice of Change to Key Date(s) for RFA-HD-20-004 "Medical Rehabilitation Research Resource (P2C Clinical Trial Optional)"
(NOT-HD-19-014)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Pre-Submission Technical Assistance Webinar and Frequently Asked Questions for RFA-HL-20-005 "Late-Stage Implementation Research Addressing Hypertension in Low- and Middle-Income Countries: Scaling Up Proven-Effective Interventions (UG3/UH3 CT Optional)"
(NOT-HL-19-696)
National Heart, Lung, and Blood Institute
Notice of Clarification: Application Types for PA-18-794, AHRQ Small Research Grant Program (R03)
(NOT-HS-19-014)
Agency for Healthcare Research and Quality
Notice of Special Interest to Highlight High Priority Research Opportunities on Suicide Prevention Crisis Services
(NOT-MH-19-025)
National Institute of Mental Health

Requests for Applications

Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
(RFA-AR-20-001)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): August 5, 2019; December 2, 2019; April 1, 2020; August 3, 2020; December 1, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
(RFA-AR-20-002)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): August 5, 2019; December 2, 2019; April 1, 2020; August 3, 2020; December 1, 2020,by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.
Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43 - Clinical Trial Not Allowed)
(RFA-AR-20-003)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): July 10, 2019
"HEAL Initiative: Limited Competition: Resource Coordinating Center for Pragmatic and Implementation Studies for the Management of Pain (PRISM) to Reduce Opioid Prescribing (U24 Clinical Trial Not Allowed)"
(RFA-AT-19-011)
National Center for Complementary and Integrative Health
Office of Behavioral and Social Science Research
Application Receipt Date(s): July 8, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.
Limited Competition Cohort Studies of HIV/AIDS and Substance Abuse (U01 Clinical Trial Not Allowed)
(RFA-DA-20-005)
National Institute on Drug Abuse
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional
(RFA-FD-19-016)
Food and Drug Administration
Application Receipt Date(s): June 25, 2019, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.

Program Announcements

NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
(PAR-19-258)
National Institute on Drug Abuse
Application Receipt/Submission Date(s): July 22, 2019; July 22, 2020; July 22, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
(PAR-19-259)
National Institute on Drug Abuse
Application Receipt/Submission Date(s): September 25, 2019; September 25, 2020; September 25, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) (PAR-19-260)
National Eye Institute
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
(PAR-19-261)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Date(s): July 1, 2019, December 16, 2019, May 1, 2020, December 15, 2020, May 3, 2021, and December 13, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.